Although our article does not possess the excellence and robustness of the ERN GENTURIS tumor surveillance guidelines for individuals with neurofibromatosis type 1, we recognize that both studies aim to improve practices among specialists in the field and increase awareness of NF1 among healthcare professionals and the general public. This evidence concerns the gene NF1 and neoplasm.